Indian Army Procurement: Panitumumab 100mg Injection Supply

Work Description - Supply Of Pvms No 013906, Inj Panitumumab 100mg

The Integrated Headquarters of the Ministry of Defence (Army), specifically the Ordnance Services/Supply/Corps Command (OSCC), through the Tender Inviting Authority DDG (Prov), O/o DGAFMS, Ministry of Defence, New Delhi 110023, invites bids for Tender Reference Number RC/26-27/84. This single-stage tender for "Goods" pertains to the critical **Supply of PVMS No 013906, Inj Panitumumab 100mg**, falling under the product category of Drugs and Pharmaceutical Products. Interested bidders can download tender documents starting from 17-Jul-2026 at 06:00 PM until 06-Aug-2026 at 10:00 AM. Bid submission commences on 27-Jul-2026 at 06:00 PM and concludes on 06-Aug-2026 at 10:00 AM. Technical and financial bids will be opened on 06-Aug-2026 at 11:00 AM at the DP portal and A Block Reception, O/o DGAFMS. A mandatory Earnest Money Deposit (EMD) of ₹21,90,900 is required, payable to "The President of India through office of DGAFMS" at New Delhi, with options for Bank Guarantee or Fixed Deposit Receipt, and EMD exemption is allowed as per tender terms. The tender fee is ₹0.00. Bids must remain valid for 120 days, and the period of work is anticipated to be 45 days. The submission requires two covers: the first for Fee/Pre-qualification/Technical documents including the RFP and supporting papers, and the second for financial details as per the BoQ excel sheet. Additional documents related to GST are also required. This procurement is essential for the operations of the Indian Army, located in New Delhi.